From: Role of omics techniques in the toxicity testing of nanoparticles
Particle | Size (nm) | Cell | Exp | Regulated pathway(s) | St | Im | De | Pr | Mo | Me | Ve | Si | O | References |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A. Transcriptomics | ||||||||||||||
Ag | 5 | L51784 | 3–6 µg/ml; 4 h | Ox. stress, DNA repair | X | X | [76] | |||||||
Ag | 5, 100 | U937 | 1–25 µg/ml; 24 h | 5 nm: ox. stress, inflammation | X | X | [80] | |||||||
Ag | 20 | Human dermal fetal fibroblasts | 3–6 µg/ml; 4 h | Cytoskeleton, energy metabolism, DNA damage | X | X | X | [122] | ||||||
Ag | 20, 30, 60 | Caco-2, MCF-7 | 5–25 µg/ml; 6–24 h | Proliferation, stress response, ox. stress | X | X | [123] | |||||||
Ag | 20, 50 | HepG2 | 2.5 µg/ml; 4–24 h | 20 nm: stress response | X | [124] | ||||||||
Ag | 20, 50 | Human dermal fibroblasts | 200 µM; 1–8 h | Cytoskeleton, insulin, HGF signaling, MAPK signaling, ATP content, apoptosis, cytoskeleton | X | X | X | X | X | [52] | ||||
Ag | 20, 50 | A549 | 1–3 µg/ml; 24–48 h | Cell cycle, ox. stress | X | X | [65] | |||||||
Ag | 20, 50 | HepG2 | 1–3 µg/ml; 24–48 h | Cell cycle progression (low dose), morphological damage (high dose) | X | [75] | ||||||||
Ag | < 100 | HeLa | 20 µg/ml; 24–48 h | Metabolic process, cellular process, stress response, apoptosis, cell cycle | X | X | X | X | [125] | |||||
Ag | 100 | Embryonic rat cells | 20 µg/ml; 48 h | Energy, metabolism, O2 transport, inflammation, molecular binding | X | X | X | [69] | ||||||
Al2O3 | < 100 | A549 | 100 µg/ml; 0–72 h | Cell death, cell cycle arrest | X | X | [81] | |||||||
Au (NH2, COOH, OH) | 17–22 | Human mesenchymal stem cells | 50 µg/ml; 4 h | TFG-β, FGF-2 | X | [126] | ||||||||
Au | 5, 30 | Caco-2 | 200–300 µM; 24–72 h | Ox. stress, apoptosis, growth inhibition | X | X | X | [127] | ||||||
Au | 20, 34, 61, 113 | Caco-2/M-cells | 0.5–64 µg/ml; 10–21 days | Ox. stress, ER stress, apoptosis | X | X | [128] |
Particle | Size (nm) | Cell | Tech | Regulated pathway(s) | St | Im | De | Pr | Mo | Me | Ve | Si | O | References |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A. Transcriptomics | ||||||||||||||
CdSe/ZnS | 8–10 | HSF-42 | 8–80 nM; 48 h | Carbohydrate binding, intracellular vesicle formation, stress response, mitosis, cytokinesis | X | X | X | X | [66] | |||||
CeO2 | 3 | Caco-2 | 170 µg/ml; 24–72 h | Mitochondrial function | X | [129] | ||||||||
CuO | 50 | A549 | 25 µg/ml; 24 h | Mitosis, cell death, p38 pathway | X | X | X | [130] | ||||||
CuO (rods, spherical) | 12, 50–80 | Caco-2 | 5–100 µg/ml; 24–120 h | Inflammation, ox. stress (rod > spherical) | X | X | [111] | |||||||
Fe3O4 (COOH, NH2, bare) | 14–18 | HCM, BE-2-C, 293T | 20–80 µg/ml; 2 days | Ox. stress, proliferation | X | X | [131] | |||||||
Fe3O4 | 32 | RAW264.7, Hepa1–6 | 30–100 µg/ml; 4–48 h | Immune effects, cell death, homeostatic processes | X | X | X | [132] | ||||||
Fe3O4 | 32 | THP-1, HepG2 | 50–100 µg/ml; 24 h | Various pathways; HepG2: cell growth, mobility, metabolism | X | X | X | [104] | ||||||
Fe2O3, SiO2, TiO2, ZnO | 3, 10, 5, 8–10 | RKO, Caco-2, HaCaT, SKMel28 | 10, 5–50, 1–5 µg/cm2; 4 h | Ox. stress response all lines, ZnO in addition protein folding | X | X | [99] | |||||||
Fe2O3, SiO2, ZnO | 100 | HEK293 | 100, 12.5 µg/ml; 24 h | Inflammation, stress, cell death | X | X | X | [107] | ||||||
MWCNT | 5–10 × 20–30 | Caco-2, diff. THP-1, small airway cells | 10–100 µg/ml; 24 h | Apoptosis, inflammation, cell adhesion | X | X | X | [93] | ||||||
PEG-silane qdots | 10–13 | IMR-90 | 8–80 mM; 48 h | Mitosis, spindle formation | X | X | [66] | |||||||
SiO2 | 10, 500 | RAW264.7 | 5–50, 250–1000 µg/ml; 24 h | Transcription, cell cycle progression, inflammation response, apoptosis, morphogenesis, differentiation | X | X | X | X | [54] | |||||
SiO2 | 12 | A549 | 0.1–6 µg/ml; 24–72 h | Ox. stress response; membrane trafficking; inflammatory response | X | X | X | [78] | ||||||
SiO2 | 12, 5–10, 10–15 | FE1 cells | 12.5–100 µg/ml; 24 h | Lysosomal genes | X | [74] | ||||||||
SiO2 | 14, 20 | A549 | 0.05–0.6 mg/ml; 2 h | Inflammation, apoptosis, matrix metalloproteinases | X | X | X | [133] | ||||||
SiO2 | 67 | A549, CCD-34Lu, H2347 | 0.1–1.5 mg/ml; 24–48 h | Inflammation, signal transduction, cell death regulation | X | X | X | [82] | ||||||
SWCNT | 1–2 × 1000–2000 | EAhy926 | 50 µg/ml; 24 h | Inflammation, ox. stress, and apoptosis | X | X | X | [53] | ||||||
TiO2 anatase | 7, 20, 200 | HaCaT | n/a; 2–24 h | Inflammation response, cell adhesion | X | X | [55] | |||||||
TiO2, ZnO | 12, 15 | Jurkat, prim macrophages, DCs | 1–10 µg/ml; 6–24 h | Ox. stress related all cell lines, cell death, cell growth, immune system; TiO2 inert | X | X | X | X | [94] | |||||
TiO2 | 7000 × 200 × 10 | Caco-2, diff. THP-1, small airway cells | 10–100 µg/ml; 24 h | Apoptosis, cell cycle, inflammation, cell adhesion, phagocytosis | X | X | X | X | X | [93] | ||||
WC, WCCo | 56, 62 | HaCaT | 30; 3 µg/ml; 3 h–3 days | Hypoxia-related response, carbohydrate metabolism, endocrine pathways | X | X | [106] | |||||||
ZnO | 20 | HaCaT | 10–80 µg/ml; 24 h | Apoptosis, ox. stress | X | X | [56] | |||||||
ZnO | 20, 60 | A549 | 25 µg/ml; 24 h | DNA damage, apoptosis, ox. stress | X | X | X | [134] | ||||||
ZnO | 28 × 96, 36 × 95, 44 × 73, 25 | Olfactory cells, human stellate cells | 2.5–10 µg/ml; 24 h | Stress response, inflammatory response; stress, cell growth and survival, cell signaling | X | X | X | X | X | |||||
A. MiRNomics | ||||||||||||||
Ag | 20 | Human neural stem cells | 10–200 µg/ml; 6–24 h | Cell cycle arrest, apoptosis, ox. stress, dysfunctional neurogenesis | X | X | X | X | [57] | |||||
Ag | 30 | Jurkat | 0.2 µg/ml; 24 h | DNA damage, apoptosis, ox. stress | X | X | [137] | |||||||
Fe2O3 | 3–7 | PC-12 | 214 µg/ml; 24 h | Apoptosis, phagocytosis, inflammation, metabolism, endocytosis | X | X | X | X | [138] | |||||
MWCNT | 100 × 13,000 | BEAS-2B | 0.25–2 µg/cm2; 1–48 h | Mitochondria, gluconeogenesis, microtubuli function | X | X | [139] | |||||||
B. Proteomics | ||||||||||||||
Au | 2.2, 5.9, 17 | K562 cells | 10 mM; 3–24 h | ER stress | X | [79] | ||||||||
Au | 5, 15 | Balb/3T3 | 58.8 µg/ml; 72 h | Cell growth, proliferation, morphology, cell cycle, ox. stress, inflammation, ECM synthesis | X | X | X | X | [71] | |||||
Ag | 20, 200 | Caco-2/TC7:HT29-MTX | 1 µg/ml; 24 h | Cytoskeleton rearrangement, cell cycle, ox. stress, metabolism | X | X | X | X | [58] | |||||
Au | 20 | Dermal fibroblasts | 200 µM; 1–8 h | Signal transduction, cytoskeleton, energy metabolism, ox. stress | X | X | X | X | [140] | |||||
Au | 20 | Small airway cells/MRC-5 | 1 nM; 72 h | Cell adhesion | X | [70] | ||||||||
NH2-Au, CuO, NH2-CdTe | 20 | THP-1 | 15, 22, 5 µg/ml; 48 h | Topoisomerase (CdTe), ox. stress (CuO), NfkB (Au) | X | X | X | [108] | ||||||
Au | 5, 30 | Caco-2 | 59 µg/ml; 72 h | Metabolism, Energy, transcription, protein, cell morphology and transport, signal transduction, growth, proliferation, antioxidant activity, apoptosis, cell adhesion, cytoskeleton orientation | X | X | X | X | X | X | [59] | |||
Au | 20 | MRC-5 | 1 nM; 72 h | Ox. stress, cytoskeleton, cell cycle regulation, DNA repair | X | X | X | X | [141] | |||||
Au | 20, 100 | LoVo | 10 µg/ml; 24 h | 100 nm: PAK, MAPK, phosphatase 2A pathway; 20 nm: cell stress, protein carbonylation | X | X | [60] | |||||||
CoO, Fe3O4, SiO2 | < 100, 13, 15 | RAW264.7 | 6.25–25 µg/ml; 24 h | ER stress, phagocytosis | X | X | [101] | |||||||
CuO | 30–50 | BEAS-2B | 0.01 µg/cm2; 24–72 h | Maintenance, protein synthesis, death/survival, cell cycle, morphology | X | X | X | X | [72] | |||||
Cu, CuO | 250 | RAW264.7 | 5–10 µg/ml; 24 h | Ox. stress response, GSH synthesis, cytoskeleton, mitochondrial proteins | X | X | X | [61] | ||||||
CuO, TiO2 | 22, 25 | Murine macrophages | 5–10, 100 µg/ml; 24 h | Ox. stress response | X | [77] | ||||||||
Fe3O4 | 10, 100 | NRK-52E | 1 ng/well; 24 h | Cell death related, ras-related, GSH-related, HSP, serpin H1, ER-resident proteins | X | X | X | [142] | ||||||
MWCNT | (0.6 × 3.6) * 10E3 | HEK | 0.4 mg/ml; 24–48 h | Metabolism, cell signaling, cell stress, vesicular trafficking, cytoskeleton | X | X | X | X | [143] | |||||
MWCNT | (0.1 × 10–20) * 10E3 | U937 | 30 µg/ml; 24 h | Metabolism, biosynthesis, stress response, differentiation | X | X | X | [144] | ||||||
MWCNT | 30 × < 1000 | A549 | 0.3–300 µg/ml, 2–24 h | Proliferation, ox. stress, cytoskeleton | X | X | X | [62] | ||||||
SiO2 | 25 | A549 | 100 µg/ml; 24 h | Apoptosis, cytoskeleton, ox. stress response, protein synthesis | X | X | X | X | [67] | |||||
SiO2 | 15, 30 | HaCaT | 10 µg/ml; 24 h | Metabolism, ox. stress, cytoskeleton, molecular chaperones, apoptosis | X | X | X | X | X | [68] | ||||
SWCNT | 1–6 × 1000–2000 | HepG2 | 0.1–100 µg/ml; 24 h | Redox regulation, signaling, cytoskeleton formation, cell growth | X | X | X | X | [145] | |||||
SWCNT, (plain, PEGylated) | (0.7–1.6 × 0.2–3) * 10E3 | PC-12 | 0.1–100 µg/ml; 24 h | Antioxidant reactivity, nucleic acid metabolism, lipid metabolism, mitochondrial function | X | X | X | [63] | ||||||
TiO2 | 18–80 | BEAS-2B | 10 µg/ml; 24 h | Stress response, metabolism, adhesion, cytoskeleton dynamics, cell growth, cell death, cell signaling | X | X | X | X | X | X | X | [146] | ||
TiO2, (coated, plain) | 20 | Human and rat macrophages | 300; 24 h//20 µg/ml; 8–48 h | Metabolic homeostasis, cytoskeleton remodeling, ox. Stress | X | X | X | |||||||
TiO2 | 24 | A549 | 2.5–50 µg/ml; 2 month | Glucose metabolism, mitochondrial function, proteasome activity, DNA damage response, p53 activation, cell cycle, proliferation | X | X | X | [148] | ||||||
ZnO, ZrO | 40 | J774 | 10 µg/ml; 24 h | Mitochondrial function, phagocytosis, DNA damage | X | X | [100] | |||||||
ZnO (Al-doped) | 20–40 | A549 | 20–500 µg/ml; 2–48 h | p53 activation, extracellular signaling | X | [149] | ||||||||
C. Metabolomics | ||||||||||||||
Ag | 10, 30, 69 | HaCaT | 10–100 µg/ml; 24 h | Glycolysis, energy production | X | [150] | ||||||||
Al2O3 | 64 | Human bronchial epithelial cells | 50–500 µg/ml; 24 h | Apoptosis, ox. stress, mitochondrial function | X | X | X | [151] | ||||||
Au | 2 | SH-SY5Y | 100 ng/ml; 2–6 h | Ox. stress, immune response | X | X | [83] | |||||||
CuO | 28 | A549 | 5–40 µg/ml; 4–24 h | Ox. stress, hypertonic stress, apoptosis | X | X | X | [64] | ||||||
CuO | < 50 | Murine bone marrow MSCs | 2–100 µg/ml; 48 h | Serine, glyceric acid, and succinic acid, glutamine | X | [32] | ||||||||
TiO2 | 5 | L929 | 100 µg/ml; 48 h | Amino acid level changes | X | [152] | ||||||||
TiO2 | < 100 | L929 | 100 µg/ml; 48 h | Carbohydrate metabolism, energy metabolism, mitochondria | X | [153] |